ClinicalTrials.Veeva

Menu

Comparison of the Effectiveness of Therapeutic Ultrasound and Phonophoresis in Chronic Low Back Pain

K

KTO Karatay University

Status

Not yet enrolling

Conditions

Low Back Pain

Treatments

Other: Phonophoresis
Other: Placebo
Other: Ultrasound

Study type

Interventional

Funder types

Other

Identifiers

NCT06959394
KaratayMST

Details and patient eligibility

About

The aim of this study is to evaluate the effects of therapeutic ultrasound and phonophoresis applications on pain, range of motion, flexibility and functional capacity in patients with chronic low back pain. The study is planned as the first scientific study comparing the effectiveness of these two physiotherapy methods in the treatment of chronic low back pain. It is aimed to make national and international publications with the data obtained at the end of the study.

The study will be conducted in a randomised single-blind, placebo-controlled design. 60 patients aged 18-30 years with chronic low back pain will be divided into 3 groups: therapeutic ultrasound (US) application, phonophoresis application and placebo US group. In addition to ultrasound and phonophoresis, TENS, infrared and low back exercises will be applied to all groups as treatment. Pain intensity (VAS), functional status (Oswestry disability index), flexibility (Sit-to-Sit test) and range of motion (goniometric measurements) will be assessed throughout the treatment period.

The study aims to make an important contribution from a clinical and economic point of view, given the increasing prevalence of low back pain worldwide and the need for treatment. The findings may guide the development of future treatment modalities.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Individuals with low back pain for more than 3 months and pain intensity more than 5 according to VAS will be included in the study

Exclusion criteria

patients who have undergone surgical operations

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 3 patient groups, including a placebo group

US
Experimental group
Description:
Participants will be treated with 1.5 W/cm2, 6 min (transmitting agent aquasonic gel) ultrasound.
Treatment:
Other: Ultrasound
Phonophoresis
Experimental group
Treatment:
Other: Phonophoresis
Placebo
Placebo Comparator group
Treatment:
Other: Placebo

Trial contacts and locations

0

Loading...

Central trial contact

mustafa savas torlak, associate professor doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems